Screener / SEC EDGAR /CIK 0001065059 /10-K filed Feb 11, 2026, compared with Feb 7, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Materials · Aggregates

Centrus Energy Corp LEU

Compare with peers Embed
The 10-K against last year's

181 changes: 37 added, 19 removed, 119 reworded, 6 quiet changes

10-K Feb 11, 2026 vs Feb 7, 2025

10-K 0001628280-26-007117 (Feb 11, 2026) vs 10-K 0001065059-25-000006 (Feb 7, 2025)

Every paragraph, and how much of it changed

One bar per paragraph, in the order of the 10-K. Height and colour show the share of its words not in the closest paragraph a year earlier; the tallest bars are new paragraphs.

Risk Factors

161 paragraphs · 17 new · 39 reworded · 7 gone · 10-K Feb 11, 2026 against Feb 7, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 20 · 48% changed Every version of it
•our certificate of incorporation gives us certain rights with respect to equity securities held (beneficially or of record) by foreign persons. If levels of foreign ownership set forth in our certificate of incorporation are exceeded, we have the right, among other things, to redeem or exchange common stock held by foreign persons, and in certain cases, the applicable redemption price or exchange value may be equal to the lower of fair market value or a foreign person’s purchase price.
Paragraph 83 · 42% changed Every version of it
Our goal is Centrus plans to continue production and modularly scale up the facility by matching production capacity with demand as demand for HALEU grows in the commercial and/or government sectors. However, our right to continue to operate the facility 16 centrifuge demonstration cascade after completion of Option 1a of Phase 2 3 of the HALEU Operation Contract depends on the award DOE exercising Option 1b of one Phase 3 or more follow-on options by entering into another contractual arrangement with the U.S. government, as well as government to facilitate continued operation of the cascade, and continued funding for operation from the U.S. government or other sources. There is no assurance that we will be awarded such options or that such funding will be available. Further, it is uncertain whether or when demand to support the scale up of the facility will materialize. If we do not secure the necessary contracts and funding and if sufficient demand does not emerge, we may not be able to continue or expand operations at that facility and may not be able to support providing HALEU fuel for the advanced reactors under development.
Paragraph 85 · 35% changed Every version of it
Our goal is to continue production and modularly scale up Regarding the facility by matching production capacity with demand as demand for existing operating HALEU grows in the commercial and/or government sectors. However, our right to continue to operate the facility after completion of Phase 2 of the HALEU Operation Contract depends on the award of one or more follow-on options by the U.S. government, as well as continued funding for operation from the U.S. government or other sources. There cascade, there is no assurance that we DOE will be awarded such award Centrus additional options or that such the U.S. government will enter into other contracts or that additional funding will be available. Further, it is uncertain whether or when demand to support the scale up of the facility will materialize. If we do not secure the necessary additional options or contracts and funding and if sufficient demand does not emerge, we may not be able to continue or expand operations at that facility operating the demonstration cascade and may not be able to support providing HALEU fuel for the advanced reactors under development. development
Paragraph 19 · 33% changed Every version of it
•our operations involve the •liability related to our use, transportation and disposal of toxic, hazardous and/or radioactive materials and could result in materials, including liability that may arise without regard to fault or negligence; and
Paragraph 80 · 27% changed Every version of it
Our ability to operate the HALEU enrichment facility we are deploying demonstration cascade pursuant to our contract with the Department of Energy under the HALEU Operation Contract after the its completion of the contract is dependent on our ability to secure additional contracts and funding from the U.S. government or other funding sources.
Paragraph 114 · 22% changed Every version of it
Substantial portion of our revenue-generating operations are conducted at our subsidiary, Enrichment Corp. The financing obtained from Enrichment Corp. funds contributes to funding our general corporate expenses, including interest payments on the 8.25% 2.25% Convertible Notes, which are were guaranteed on a limited and subordinated basis by Enrichment Corp. Enrichment Corp. also has pledged its assets as security for the 8.25% 2.25% Convertible Notes. As a wholly-owned subsidiary of Centrus, Enrichment Corp. has its own set of creditors and a separate board of directors, the Enrichment Board, who are elected by Centrus. Current Centrus raised $388.7 million under the issuance of the 2.25% Convertible Notes in 2024, $782.4 million under the issuance of the 0% Convertible Notes in 2025, and future $54.7 million and $523.7 million in 2024 and 2025, respectively, under the Company’s ATM program, which contributes to funding our general corporate expenses and support are conditional and dependent on Enrichment Corp.’s own financial condition and a determination by the Enrichment Board that such funding is in the interest of Enrichment Corp. working capital.
Paragraph 77 · 19% changed Every version of it
The DOE continues to pursue the availability of HALEU for the ARDP and for the advanced reactor market and the availability of domestically enriched uranium in a quantity that would be sufficient to address a supply disruption and gaps in domestic production and enrichment and issued separate RFPs for the deconversion of HALEU, the production of HALEU and domestic production of LEU. The DOE awarded ACO the HALEU Production Contract, the HALEU Deconversion Contract and the LEU Production Contract. These IDIQ contracts were awarded to multiple successful bidders, after which the awardees will compete for individual task orders. The ultimate dollar amount under each contract and the potential scale of the expansion supported will depend upon the scope of task orders that DOE may subsequently issue under each of the contracts for which we will compete. Although we believe On January 5, 2026, the DOE announced that we ACO was awarded a $900.0 million task order to expand its uranium enrichment facility in Piketon, Ohio, to include commercial-scale production of HALEU under the HALEU Production Contract. The task order is subject to negotiation of a definitive agreement and there are well positioned, there no guarantees about whether or when funding by the DOE for such expansion would be awarded. On the same date, ACO was notified that another bidder, and not ACO, was awarded a $900.0 million task order in response to a request for proposals under the LEU Production Contract. There is no assurance that we will be awarded any additional task orders under any of our contracts and, if awarded, the nature, timing and amount of the task orders that may be issued under an award is uncertain.
Paragraph 39 · 18% changed Every version of it
•pandemics, armed conflicts (including between Russia and Ukraine, between Israel and Hamas, and between the war in Ukraine), United States and Venezuela), government actions and other events that disrupt supply chains, production, transportation, payments and importation of nuclear materials or other critical supplies or services;

MD&A

170 paragraphs · 20 new · 78 reworded · 12 gone · 10-K Feb 11, 2026 against Feb 7, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 15 · 49% changed
The DOE continues to pursue the availability of HALEU for the ARDP and for the advanced reactor market and the availability of domestically enriched uranium in a quantity that would be sufficient to address a supply disruption and gaps in domestic production and enrichment and issued separate RFPs for the deconversion enrichment. Congress appropriated a total of HALEU, the production of HALEU and domestic production of LEU. The DOE awarded multiple IDIQ contracts approximately $3.4 billion to the successful bidders, after which DOE to jumpstart U.S. nuclear fuel production, including both LEU and HALEU enrichment. Based on this funding, the DOE issued a series of three RFPs covering HALEU production, HALEU deconversion, and LEU production. In late 2024, the DOE made initial selections under each of the RFPs. Centrus was among the awardees will compete for individual task orders. The total aggregate funding to be awarded all three RFPs under IDIQ structures (the HALEU Deconversion Contract, HALEU Production Contract, and the contracts is $3.4 billion with a minimum of $2.0 million for each contract which is partly funded through the IRA. Executive Order 14154, issued on January 20, 2025, directed executive agencies of the U.S. federal government to pause the distribution of federal funding, including funding appropriated under the IRA, pending a review of programs for issuing grants, loans, contracts, or any other financial disbursements. The timing of the pause and subsequent review, as well as the outcome of such review, remain uncertain. LEU Production Contract.
Paragraph 115 · 46% changed
Revenue from the Technical Solutions segment Equity-related compensation expense was $92.1 $5.8 million and $51.2 $1.5 million for the year ended December 31, 2024 2025 and 2023, 2024, respectively, an increase of $40.9 $4.3 million (or 80%). Revenue generated by the HALEU Operation Contract increased by $41.3 287%). This increase was primarily as a result of a non-cash charge of $3.6 million primarily due to the transition reclassification of certain Board restricted stock unit grants from Phase 1 equity to Phase 2, in late 2023, which shifted the arrangement from a cost-share to a cost-plus-incentive-fee. liability.
Paragraph 157 · 44% changed
The Company filed a an automatic shelf registration statement on Form S-3 (Registration Statement (File No. 333-272984) 333-291305) with the SEC on June 28, 2023, November 6, 2025, which became effective on July 10, 2023. was supplemented by a prospectus supplement dated November 6, 2025. Pursuant to this shelf registration statement, these filings, the Company may offer and sell up to $200.0 million $1.0 billion in securities, in aggregate. The Company retains broad discretion over the use of the net proceeds from the sale of the securities offered. Unless otherwise specified in any prospectus supplement, we currently intend to use the net proceeds from the sale of our securities offered under this prospectus for working capital and general corporate purposes including, but not limited to, capital expenditures, working capital, repayment of indebtedness, potential acquisitions and other business opportunities. Pending any specific application, we may initially invest funds in short-term marketable securities or apply them to the reduction of indebtedness.
Paragraph 43 · 44% changed
In addition to limitations targeted specifically at imports of LEU, the expanding sanctions imposed by the United States and foreign governments on the mechanisms used to make payments to Russia and to obtain services, including transportation and other services, have increased the risk that implementation of the TENEX Supply Contract may be disrupted in the future. For example, effective January 10, 2025, the U.S. Secretary of the Treasury, made a determination pursuant to section l(a)(i) of Executive Order 14024, to apply certain sanctions to any person determined, pursuant to that section, to operate or have operated in “the energy sector of the Russian Federation economy.” TENEX’s financial institutions have had challenges in accepting payments denominated in U.S. dollars and the Company and TENEX have agreed to delay certain payments under the TENEX Supply Contract as the parties review payment processing options. Additionally, on April 17, 2025, the Office of the USTR released a notice issuing the results of its investigation into China’s dominance in the maritime, logistics, and shipbuilding sectors pursuant to Section 302(a) of the Trade Act of 1974, as amended. The USTR imposed new service fees on Chinese-built vessels entering U.S. ports above certain capacity. Our shipper of Russian LEU from Russia to the U.S. uses ships manufactured in China which happen to be exempt from the new fees under this notice. However, these fees would be significant if they were to be imposed on our shipper. If the USTR changes its position and does not exempt the type of vessel our shipper uses, then the additional fees imposed on our shipper for docking at U.S. ports would be cost prohibitive, would have a significant impact on our ability to transport Russian LEU and would also have a material adverse effect on our financial position and results of operations. If the U.S. government were to prohibit companies and individuals from engaging in transactions with Rosatom and its subsidiaries, including TENEX, the Company and its suppliers could not implement the TENEX Supply Contract absent a license or other authorization from the sanctioning government.
Paragraph 113 · 44% changed
Gross profit for the Technical Solutions segment was $17.6 $6.0 million and $7.0 $17.6 million for the year ended December 31, 2024 2025 and 2023, 2024, respectively, an increase a decrease of $10.6 $11.6 million (or 151%). 66%). The increase decrease was primarily attributable to the factors discussed in Revenue and Cost of Sales above. Because of the delay in completing Phase 2 of the HALEU Operation Contract and the transition from Phase 1 (cost-share) to Contract, DOE extended Phase 2 (cost-plus-incentive-fee) in late 2023. through January 31, 2026. Costs incurred subsequent to November 2024 have not yet been subject to a fee as this portion of Phase 2 remains undefinitized and is subject to negotiation.
Paragraph 16 · 44% changed
On October 4, 2024, Each of these IDIQ awards carries a $2.0 million contract minimum for each awardee and is subject to an overall contract ceiling covering all awardees. Under the IDIQ awards, the DOE selected ACO can issue task orders to the awardees and five other awardees under the November 28, 2023 solicitation aimed at HALEU deconversion, a subsequent step in the HALEU production process. then allocate available funding to those task orders. The contract has a minimum ultimate value of $2.0 million and a maximum value of $0.8 billion for all awardees. On October 16, 2024, DOE selected ACO and three other awardees under the January 9, 2024 competitive solicitation aimed at expanding domestic commercial production of HALEU, which is needed awards to fuel many of the next-generation nuclear reactor designs currently under development. The contract has a minimum value of $2.0 million and a maximum value of $2.7 billion for all awardees. On December 10, 2024, DOE selected ACO and five other awardees under the June 27, 2024 solicitation aimed at expanding domestic commercial production of LEU. The award has a minimum contract value of $2.0 million and a maximum value of $3.4 billion over a ten-year period. The ultimate dollar amount under each contract Centrus, and the potential scale of the expansion supported supported, will depend upon the scope of task orders that DOE may subsequently issue to Centrus under the contracts for which we will the Company intends to compete. Although we believe that we are well positioned, there There is no assurance that we will be awarded any additional task orders under any of these our contracts and, if awarded, the nature, timing and amount of the task orders that may be issued under an award is uncertain. The aggregate total appropriated funding for all awardees is $3.4 billion. any award.
Paragraph 154 · 42% changed
On November 7, 2024, The proceeds from both the Company issued, in a Rule 144A offering, 2.25% Convertible Notes with an aggregate principal amount of $402.5 million, due November 1, 2030, unless earlier repurchased, redeemed or converted. The proceeds from and the 2.25% 0.0% Convertible Notes will be used for general working capital and corporate purposes, which may include investment in technology development or deployment, repayment or repurchase of outstanding debt, capital expenditures, potential acquisitions and other business opportunities and purposes. There are no required principal payments prior to the maturity of the 2.25% Convertible Notes. The 2.25% Convertible Notes bear interest at an annual rate of 2.25%, payable semi-annually in arrears on May 1 and November 1 of each year, beginning on May 1, 2025. The Company incurred approximately $13.8 million in issuance costs for the issuance of the 2.25% Convertible Notes. For further details refer to Liquidity and Capital Resources.
Paragraph 31 · 38% changed
While the monthly price indicators have increased for several years, the uranium enrichment segment of the nuclear fuel market remains oversupplied and faces uncertainty about future demand for nuclear power generation. However, without Russian supply, the global market would be undersupplied for uranium enrichment. Changes Recent data from the International Trade Commission shows a significant increase in the importation of enriched uranium into the U.S. from China beginning in 2023. If this trend continues, it will likely result in significant changes in the competitive landscape that will affect pricing trends, change affect customer spending patterns, create uncertainty and create uncertainty. likely have a negative impact on our business. To address these changes, we have taken steps to adjust our cost structure; we may seek further adjustments to our cost structure and operations and evaluate opportunities to grow our business organically or through acquisitions and other strategic transactions.

A paragraph is matched with the one last year that shares the most of its words; under half in common makes it new. The paragraphs shown are the 8 reworded the most in each section.

The paragraph that changed most in each section

The redline

Marked against last year's 10-K: cut words struck through, new words highlighted.

MD&A280 words changed in this paragraph; it is 30% similar to last year's version.
We were On November 10, 2022, the DOE awarded the HALEU Operation Contract to the Company with a base contract value of approximately $150.0 million in November 2022 which provided for a 50/50 cost share for two phases through 2024. Phase 1 of included an approximately $30.0 million cost-share contribution from Centrus matched by approximately $30.0 million from the base contract DOE to complete construction of the cascade, begin operations and complete produce the initial, small quantity initial 20 kilograms of demonstration HALEU. The HALEU UF6. On November 7, 2023, the Company completed announced that it made its first contractual delivery of HALEU UF6 to the DOE, completing Phase 1 in 1. During November 2023. 2023, the Company transitioned to Phase 2 includes of the HALEU Operation Contract, which included production of 900 kilograms of HALEU UF6 for one production year, as well as continued operations and maintenance of the cascade. Phase 2 included an initial contract value of approximately $90.0 million and compensation on a cost-plus-incentive-fee basis. Finally, cost-plus-incentive-fee-basis. The DOE owns the HALEU produced from the demonstration cascade. The DOE extended the HALEU Operation Contract includes options for Phase 2 period of performance through January 31, 2026 to allow the government Company to unilaterally extend performance for up to an additional nine years, comprised complete outstanding change orders. As of three options of three years each, also on a cost-plus-incentive-fee basis. December 31, 2025, the Phase 2 contract value and related funding is approximately $170.1 million. The Company also is performing additional work on infrastructure and facility repairs and costs associated with 5B Cylinder refurbishment under contract modifications or DOE technical direction. On November 5, 2024, the HALEU Operation Contract Phase 2 period of performance was extended to June 30, 2025. DOE has increased the Phase 2 contract value and related funding to approximately $129.0 million. The Company’s goal is to modularly scale up the facility as demand for HALEU grows in the commercial and government sectors, subject to the availability of funding and/or contracts to purchase the output of the plant. modifications.

Source: Item 7, 10-K 0001628280-26-007117 vs Item 7, 10-K 0001065059-25-000006

Accounting Policies137 words changed in this paragraph; it is 80% similar to last year's version.
In May 2024, the U.S. passed the Import Ban Act that bans imports of LEU from Russia into the U.S., subject to the issuance of waivers by the DOE. Centrus has received two three waivers from the DOE authorizing the importation of Russian LEU committed for delivery to our U.S. and foreign customers in 2024 and 2025 through 2027 and authorizing the importation of Russia Russian LEU for processing and reexport to our foreign customers in 2025. On December 11, 2024, the Company filed a third waiver request application to allow for importation of LEU from Russia in 2026 and 2027 for use in future sales to our U.S. customers. On November 14, 2024, Russia passed the Russian Decree, effective through December 31, 2025, 2027, that rescinded TENEX’s general license to export LEU to the United States or to entities registered in the United States. Beginning in November 2024, TENEX was required to obtain a specific export license from the Russian authorities in order for it to make each of the remaining 2024 and 2025 shipments of LEU to Centrus and for shipments to Centrus in 2025. Centrus has been informed that through 2027. Except for the initial delay, TENEX has received three specific licenses to date which allow TENEX satisfy shipments to export LEU to Centrus in the U.S. for our pending orders. Centrus will use the majority regular course of this LEU to satisfy pending orders to a single customer on a delayed basis in reliance on our contractual rights. TENEX has informed Centrus of its plan to seek additional export licenses to meet its delivery obligations under the TENEX Supply Contract for our other pending and future orders. business. However, Centrus has been informed that there is no certainty whether such licenses will be issued by the Russian authorities and if issued, whether they will be issued in a timely manner or rescinded prior to the shipment taking place. Canada has imposed sanctions on ocean transportation of Russian LEU, but has given a permit to the Company’s carrier that extends to March 2027. Additional sanctions or other restrictions by the U.S. or foreign governments (including the Russian government) could be imposed or the existing Canadian permit might not be extended. Any sanctions or restrictions directed at trade in LEU from Russia or the parties involved in such trade or otherwise, including denial or non-renewal of licenses or permits, could interfere with, or prevent, implementation of the TENEX Supply Contract.

Source: 10-K text, Note 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, 10-K 0001628280-26-007117 vs 10-K text, Note 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, 10-K 0001065059-25-000006

Risk Factors127 words changed in this paragraph; it is 49% similar to last year's version.
Our goal is Centrus plans to continue production and modularly scale up the facility by matching production capacity with demand as demand for HALEU grows in the commercial and/or government sectors. However, our right to continue to operate the facility 16 centrifuge demonstration cascade after completion of Option 1a of Phase 2 3 of the HALEU Operation Contract depends on the award DOE exercising Option 1b of one Phase 3 or more follow-on options by entering into another contractual arrangement with the U.S. government, as well as government to facilitate continued operation of the cascade, and continued funding for operation from the U.S. government or other sources. There is no assurance that we will be awarded such options or that such funding will be available. Further, it is uncertain whether or when demand to support the scale up of the facility will materialize. If we do not secure the necessary contracts and funding and if sufficient demand does not emerge, we may not be able to continue or expand operations at that facility and may not be able to support providing HALEU fuel for the advanced reactors under development.

Source: Item 1A, 10-K 0001628280-26-007117 vs Item 1A, 10-K 0001065059-25-000006

Legal Proceedings38 words changed in this paragraph; it is 93% similar to last year's version.
On November 27, 2023, the Company, Enrichment Corp. and six other DOE contractors who operated facilities at the Portsmouth GDP were named as defendants in a complaint filed by Joshua Shaw in the U.S. District Court in the Southern District of Ohio, Eastern Division (the “Shaw Complaint”). Joshua Shaw was diagnosed with Acute Myeloid Leukemia (“AML”) in August 2008 and after going through chemotherapy continues to experience aftereffects of AML, including anxiety and fatigue. The Shaw Complaint alleges that the defendants released radiation into the environment exposing Mr. Shaw to radiation in violation of the Price-Anderson Act and causing Mr. Shaw’s AML and other injuries. Mr. Shaw seeks monetary damages in nature of past and future medical expenses for treatment and care, pain and suffering and punitive damages, among others. On February 26, 2024, the Company, Enrichment Corp. and the other defendants filed their motion to dismiss the Shaw Complaint, which was thereafter amended on March 14, 2024. On March 28, 2024, the Company, Enrichment Corp. and the other defendants filed their motion to dismiss the amended Shaw Complaint, and, on May 31, 2024 filed their reply to support their motion to dismiss the amended Shaw Complaint. On March 31, 2025, the Court did not grant the Company’s motion to dismiss the Complaint for being time-barred. On April 14, 2025, the Company, Enrichment Corp., and the other defendants filed their answer to the amended complaint. The Company and Enrichment Corp. believe that their operations at the Portsmouth GDP site were fully in compliance with the NRC’s regulations. Further, the Company and Enrichment Corp. believe that any such liability should be indemnified under the Price-Anderson Act. The Company and Enrichment Corp. have provided notifications to the DOE required to invoke indemnification under the Price-Anderson Act and other contractual provisions.

Source: Item 3, via Note 17 – COMMITMENTS AND CONTINGENCIES, 10-K 0001628280-26-007117 vs Item 3, via Note 17 – COMMITMENTS AND CONTINGENCIES, 10-K 0001065059-25-000006

Sentences and paragraphs added, removed or reworded

Every change, by type

Sentences and paragraphs of LEU's Risk Factors and MD&A, 10-K Feb 11, 2026 against 10-K Feb 7, 2025. Each links to the text at sec.gov.

Quiet changes are sentences kept from last year with one to four words changed, at least one of them a hedge, a modal or a qualifier (may, could, will, not, significant, material…). A year or date rolling forward is not counted.

The full word list

adverse, adversely, all, although, anticipate, anticipates, any, approximately, believe, believes, can, cannot, certain, could, expect, expects, generally, however, if, intend, intends, largely, likely, many, material, materially, may, might, most, must, never, no, not, possible, primarily, probable, should, significant, significantly, some, substantial, substantially, unlikely, will, would

AddedRisk Factors
•our operations being out of compliance with applicable regulations, including those issued by the U.S. government, including the NRC and the DOE, and the States of Ohio and Tennessee;
Read it in 10-K Feb 11, 2026 at sec.gov
AddedRisk Factors
There have recently been significant changes to international trade policies and tariffs affecting imports and exports. The U.S. has implemented a range of new tariffs and increases to existing tariffs, and, in response to the tariffs announced by the U.S., other countries have imposed new or increased tariffs on certain exports from the United States. There is currently significant uncertainty about the future relationship between the United States and other countries with respect to trade policies, government regulations and tariffs. We cannot predict whether, and to what extent, current tariffs will continue, or trade policies will change in the future.
Read it in 10-K Feb 11, 2026 at sec.gov
Show the other 65
AddedRisk Factors
Additionally, on April 17, 2025, the Office of the United States Trade Representative (“USTR”) released a notice issuing the results of its investigation into China’s dominance in the maritime, logistics, and shipbuilding sectors pursuant to Section 302(a) of the Trade Act of 1974, as amended. The USTR imposed new service fees on Chinese-built vessels entering U.S. ports above certain capacity. Our shipper of Russian LEU from Russia to the U.S. uses ships manufactured in China which happen to be exempt from the new fees under this notice. However, these fees would be significant if they were to be imposed on our shipper.
Read it in 10-K Feb 11, 2026 at sec.gov
AddedRisk Factors
On September 8, 2025, the U.S. officially removed import tariffs on uranium as part of a broader executive order aimed at strengthening domestic supply chains and supporting strategic industries. However, there is draft legislation in the U.S. Congress designed to impose potentially significant tariffs on Russian goods. These developments are ongoing and are subject to change, including the imposition of additional tariffs and retaliatory measures by these and other countries. Depending on their extent, scope and duration, these tariffs and retaliatory measures may result in increased costs for any equipment and other goods we require to operate and develop our projects in accordance with our current plans. At the same time, it is possible that these tariffs and other measures may benefit certain aspects of our business, including by increasing demand for uranium produced in the U.S. Although discussions continue regarding potential economic arrangements between certain countries, there remains significant uncertainty over the scope, impact and duration of any tariffs and retaliatory measures, and they may, among other things, adversely impact general economic conditions, including the market and demand for uranium and our business financial condition and results of operations. For further discussion of these risks and uncertainties, refer to Part I, Item 1A, Risk Factors - The current war in Ukraine and related international or U.S. sanctions, tariffs, and restrictions on trade, and the Russian response thereto, could have a material adverse impact on our business, results of operations, and financial condition.
Read it in 10-K Feb 11, 2026 at sec.gov
AddedRisk Factors
We may not be able to successfully implement our planned expansion projects in Piketon, Ohio and Oak Ridge, Tennessee, which could adversely affect our business, financial condition, and results of operations.
Read it in 10-K Feb 11, 2026 at sec.gov
AddedRisk Factors
As described in further detail in Part II, Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, we are pursuing several expansion initiatives, including the expansion of the manufacturing capacity at our facility in Oak Ridge, Tennessee and a major expansion of our uranium capacity in Piketon, Ohio. ACO was awarded a $900.0 million task order from the DOE to expand its uranium enrichment facility in Piketon, Ohio, which is subject to negotiation of a definitive agreement. These projects are complex, costly, and subject to significant uncertainties. Delays, cost overruns, or operational disruptions could materially impact our ability to achieve the anticipated benefits of these initiatives. Our ability to complete expansion projects on time and within budget depends on a variety of factors, many of which are outside our control. These include challenges related to DOE funding, permitting, zoning, environmental reviews, supply chain constraints, and the availability and performance of contractors, subcontractors, and construction materials. Adverse weather, labor disputes, supply chain disruptions or delays, changing market conditions, unexpected engineering issues, or changes in regulatory requirements could further delay or disrupt construction activities.
Read it in 10-K Feb 11, 2026 at sec.gov
RemovedRisk Factors
•a small number of Class A stockholders, who also have significant holdings of the Company’s 8.25% Notes, may be motivated by interests that are not aligned with the Company’s other Class A stockholders; and
Read it in 10-K Feb 7, 2025 at sec.gov
RemovedRisk Factors
•our operations are regulated by the U.S. government, including the NRC and the DOE as well as the States of Ohio and Tennessee. Recent U.S. government administrations have relied on executive orders in lieu of federal legislation to implement regulatory policy and objectives, which could exacerbate regulatory unpredictability. Further, recent U.S. Supreme Court decisions have the potential to redefine the power of federal agencies to interpret and apply federal regulations, which could impact various regulatory rules affecting our business in ways that could affect our business, prospects and operations, and our financial performance positively or negatively;
Read it in 10-K Feb 7, 2025 at sec.gov
RemovedRisk Factors
In Phase 2, we expect to continue operating for a full year at an annual production rate of 900 kilograms of HALEU, but there is no assurance that we will produce 900 kilograms by June 2025.
Read it in 10-K Feb 7, 2025 at sec.gov
RemovedRisk Factors
•placing certain restrictions on the ability of our subsidiary, Enrichment Corp., to transfer cash and other assets to us, which could constrain our ability to pay dividends on our Common Stock or to fund our commitments or the commitments of our other subsidiaries, pursuant to the indenture governing our 8.25% Notes, subject to certain exceptions; and
Read it in 10-K Feb 7, 2025 at sec.gov
RemovedRisk Factors
•restricting our ability to engage in certain mergers or acquisitions pursuant to the indenture governing our 8.25% Notes which also require us to offer to repurchase all such outstanding notes at 101% of their outstanding principal amount in the event of certain change of control events.
Read it in 10-K Feb 7, 2025 at sec.gov
RemovedRisk Factors
A small number of Class A stockholders, who also have significant holdings of the Company’s 8.25% Notes, may be motivated by interests that are not aligned with the Company’s other Class A stockholders.
Read it in 10-K Feb 7, 2025 at sec.gov
RemovedRisk Factors
Currently, a small number of persons who also are Class A stockholders collectively own approximately 33% of our 8.25% Notes. As a result, these stockholders may have interests that differ from the remainder of the holders of our Class A Common Stock, and, as a result, may vote or take other actions in a way adverse to other holders of Class A Common Stock.
Read it in 10-K Feb 7, 2025 at sec.gov
RewordedRisk Factors
However, our right to continue to operate the facility 16 centrifuge demonstration cascade after completion of Option 1a of Phase 2 3 of the HALEU Operation Contract depends on the award DOE exercising Option 1b of one Phase 3 or more follow-on options by entering into another contractual arrangement with the U.S. government, as well as government to facilitate continued operation of the cascade, and continued funding for operation from the U.S. government or other sources.
Read it in 10-K Feb 11, 2026 at sec.gov
RewordedRisk Factors
Our ability to operate the HALEU enrichment facility we are deploying demonstration cascade pursuant to our contract with the Department of Energy under the HALEU Operation Contract after the its completion of the contract is dependent on our ability to secure additional contracts and funding from the U.S. government or other funding sources.
Read it in 10-K Feb 11, 2026 at sec.gov
RewordedRisk Factors
There Regarding the existing operating HALEU cascade, there is no assurance that we DOE will be awarded such award Centrus additional options or that such the U.S. government will enter into other contracts or that additional funding will be available.
Read it in 10-K Feb 11, 2026 at sec.gov
RewordedRisk Factors
For example, the indenture indentures governing the 0% Convertible Notes and the 2.25% Convertible Notes requires require us to repurchase the notes for cash upon the occurrence of a fundamental change (as defined in the indenture indentures governing the 0% Convertible Notes and the 2.25% Convertible Notes) and, in certain circumstances, to increase the conversion rate for a holder who converts their 0% Convertible Notes or 2.25% Convertible Notes in connection with a make-whole fundamental change (as defined in the indenture governing the 2.25% Convertible Notes). respective indentures).
Read it in 10-K Feb 11, 2026 at sec.gov
RewordedRisk Factors
The DOE has granted the Company waivers allowing it to import LEU from Russia for deliveries already committed by the Company to its U.S. customers in years 2024 and 2025 and allowing the importation of LEU from Russia for processing and reexport to our foreign customers scheduled in 2025. customers.
Read it in 10-K Feb 11, 2026 at sec.gov
RewordedRisk Factors
Centrus has been informed that For each of our orders to date, TENEX has received three specific licenses to date which allow TENEX to export LEU to the U.S. for our pending orders.
Read it in 10-K Feb 11, 2026 at sec.gov
RewordedRisk Factors
We continue to have significant long-term liabilities, including the indebtedness under our 0% Convertible Notes and 2.25% Convertible Notes, which mature in August 2032 and November 2030 and our 8.25% Notes, which mature in February 2027. 2030, respectively.
Read it in 10-K Feb 11, 2026 at sec.gov
RewordedRisk Factors
If we do not secure the necessary additional options or contracts and funding and if sufficient demand does not emerge, we may not be able to continue or expand operations at that facility operating the demonstration cascade and may not be able to support providing HALEU fuel for the advanced reactors under development. development
Read it in 10-K Feb 11, 2026 at sec.gov
RewordedRisk Factors
There is no certainty that DOE will grant our waiver request and further waivers and, if granted, whether it such waiver would be granted in a timeframe that would meet our customers’ needs in 2026 or 2027. needs.
Read it in 10-K Feb 11, 2026 at sec.gov
RewordedRisk Factors
In addition, the existence of the 2.25% Convertible Notes notes may encourage short selling by market participants that engage in hedging or arbitrage activity, and anticipated conversion of the 2.25% Convertible Notes notes into shares of our common stock could depress the price of our common stock. Common Stock.
Read it in 10-K Feb 11, 2026 at sec.gov
RewordedRisk Factors
On November 14, 2024 2024, the government of the Russian Federation passed the Russian Decree, effective through December 31, 2025, 2025 (and later extended until December 31, 2027), that rescinded TENEX’s general license to export LEU to the United States or to entities registered in the United States.
Read it in 10-K Feb 11, 2026 at sec.gov
RewordedRisk Factors
Although we believe that we are well positioned, there There is no assurance that we will be awarded any additional task orders under any of our contracts and, if awarded, the nature, timing and amount of the task orders that may be issued under an award is uncertain.
Read it in 10-K Feb 11, 2026 at sec.gov
Quiet changesRisk Factors
There is no assurance that we will be awarded any additional task orders under any of our IDIQ contracts and, if awarded, the nature, timing and amount of the task orders that may be issued under an award is uncertain.
Read it in 10-K Feb 11, 2026 at sec.gov
AddedMD&A
On June 17, 2025, the DOE amended the HALEU Operation Contract to divide the first three-year option period into a first option period of one year (“Option 1a”) and a second option period of two years (“Option 1b”). The amendment established a target cost and fee for Option 1a of approximately $99.3 million and $8.7 million, respectively, and a target cost and fee for Option 1b of $163.5 million and $15.2 million, respectively. The DOE exercised Option 1a and extended the period of performance to June 30, 2026. As of December 31, 2025, Option 1a is funded for the contract value of $108.2 million. Additionally, the amendment acknowledged that the estimated cost associated with Option 1b is insufficient to support full performance due to known cost increases since the award of the HALEU Operation Contract and indicated that the Company will need to submit a revised cost proposal for review and negotiation prior to DOE’s consideration of Option 1b.
Read it in 10-K Feb 11, 2026 at sec.gov
AddedMD&A
Under the HALEU Operation Contract, the Company has submitted several change order requests for work being performed on infrastructure, facility repairs, and 5B Cylinders. The additional work is being performed under the DOE contracting officer’s approval or contract modifications. On September 28, 2023, the DOE modified the HALEU Operation Contract to incorporate additional scope for infrastructure and facility repairs, and costs associated with 5B Cylinder refurbishment, for an estimated additional contract value of $5.8 million, without a cost-share provision. As of December 31, 2025, DOE was obligated for costs up to the contract value of $8.8 million for the additional scope work. The DOE modified the HALEU Operation Contract and increased funding in January 2026 and is now obligated for costs up to the current contract value of $9.7 million. For further details refer to Part I, Item 1, Business - Technical Solutions - Government Contracting.
Read it in 10-K Feb 11, 2026 at sec.gov
AddedMD&A
On November 6, 2024, DOE issued requests for task order proposals under each of the HALEU Production Contract and the HALEU Deconversion Contract for respective optimization studies to support DOE in establishing the commercial production of HALEU and commercial deconversion of HALEU. On January 9, 2025, we submitted our proposals in response to these requests for task order proposals. On August 14, 2025, DOE, without making any awards under the first task order proposal request, issued a second request for task order proposals under the HALEU Production Contract. The second request provided $900.0 million to support the deployment of commercial HALEU enrichment capacity. On January 5, 2026, the DOE announced that ACO was selected for award of a $900.0 million task order to expand its uranium enrichment facility in Piketon, Ohio, to include commercial-scale production of HALEU. The award also includes options, at the DOE’s discretion, for up to $170.0 million to produce and deliver HALEU to the DOE. The task order is subject to negotiation of a definitive agreement and there are no guarantees about whether or when funding by the DOE for such expansion would be awarded or whether we will successfully perform any awarded contract.
Read it in 10-K Feb 11, 2026 at sec.gov
AddedMD&A
On March 30, 2025, the Company submitted its proposal in response to a request for task order proposals from the DOE for a report and additional deliverables under the LEU Production Contract. On April 11, 2025, the Company was awarded a time and materials task order with a total award ceiling of approximately $0.5 million.
Read it in 10-K Feb 11, 2026 at sec.gov
AddedMD&A
On September 25, 2025, Centrus announced plans for a major expansion of its uranium capacity in Piketon, Ohio, including plans for large-scale production of both LEU and HALEU to meet commercial and government requirements. In December 2025, the Company initiated design work on a 150,000 square foot training, operations and maintenance Facility in Piketon, Ohio – a critical piece of site infrastructure necessary to support the company's plans for a major expansion of its uranium enrichment capacity in Piketon. The project involves a significant renovation and rehabilitation of an existing, largely vacant building on the site of the American Centrifuge Plant, with construction activities set to begin early 2026. The facility is expected to include a mix of office space, training facilities, and maintenance bays to support plant operations. Also in December 2025, the Company began domestic centrifuge manufacturing to support commercial LEU enrichment activities at its Piketon, Ohio, facility. This strategic move enables the Company to capitalize on its many first-mover advantages in U.S.-owned domestic uranium enrichment, and marks one of the most consequential transformations in the Company's and the United States' uranium enrichment history. Centrus plans to leverage its multi-billion-dollar uranium enrichment expansion to meet its growing backlog of $2.3 billion in contingent LEU sales to U.S. and international customer contracts, and targets future commercial-scale production of HALEU, as well. There is no assurance that we will successfully complete our announced expansion of our uranium capacity in Piketon, Ohio, or execute plans for large-scale production of both LEU and HALEU to meet commercial and government requirements. For further details, see Part 1, Item 1, Business - Low Enriched Uranium – LEU Backlog and Technical Solutions - Technical Solutions Backlog.
Read it in 10-K Feb 11, 2026 at sec.gov
AddedMD&A
On February 9, 2026, ACO entered into an engineering, procurement and construction contract with Fluor Federal Services, Inc. (“Fluor”), a third-party contractor, for the commercial expansion and deployment of LEU and HALEU production capability at the American Centrifuge Plant (ACP) in Piketon, Ohio. The contract provides for compensation on a time and materials basis at agreed labor rates and extends until the completion of performance.
Read it in 10-K Feb 11, 2026 at sec.gov
AddedMD&A
Under the contract, Fluor’s services will include design, engineering, procurement, construction and construction management, and related services to support full commercial HALEU and LEU operations. Fluor will be paid a reimbursable amount for all costs incurred in connection with the relevant work (such as labor, equipment, materials, and other direct costs), plus other agreed upon margins. ACO will fund the services by establishing a zero-balance and escrow general disbursement account that will be administered in accordance with agreed-upon procedures. ACO will authorize funds incrementally in accordance with stage gates and Fluor’s performance is limited by the authorized funding. The Company has not incurred any costs under the contract and has not deposited any funds into the escrow account. The total price paid to the Contractor will depend on the scope of the services authorized by the ACO, in accordance with the terms of the contract.
Read it in 10-K Feb 11, 2026 at sec.gov
AddedMD&A
The contract may be terminated or suspended by ACO or Fluor for cause, or by ACO for convenience, in which case Fluor is entitled to compensation for services and any applicable fee provided through termination. In the event of cancellation by ACO for reasons other than default, Fluor is also entitled to a cancellation fee in the initial amount of $24.0 million on the contract effective date, subsequently decreasing by $2.0 million per month until reaching $0.
Read it in 10-K Feb 11, 2026 at sec.gov
AddedMD&A
Pursuant to a notice of redemption issued on February 24, 2025, on March 26, 2025, the Company redeemed all 8.25% Notes at a redemption price equal to 100% of the $74.3 million aggregate principal amount, together with any accrued and unpaid interest. The Company recorded a gain of $11.8 million related to the extinguishment of the long-term debt.
Read it in 10-K Feb 11, 2026 at sec.gov
AddedMD&A
On June 30, September 30, and December 31, 2025, the Company provided notice to holders of the 2.25% Convertible Notes that the notes became convertible at the option of the holders beginning on the first day of the respective subsequent quarter, and ending at the close of business on the last day of said quarter. The notes are convertible at a conversion rate of 10.2564 shares of Class A Common Stock per $1,000 principal amount of notes, which is equivalent to a conversion price of approximately $97.50 per share of Class A Common Stock. The 2.25% Convertible Notes became convertible because the last reported sale price of shares of the Class A Common Stock, for at least 20 trading days during the period of 30 consecutive trading days ending on, and including, the last trading day of each of the three calendar quarters, was greater than 130% of the conversion price in effect on each applicable trading day.
Read it in 10-K Feb 11, 2026 at sec.gov
AddedMD&A
On April 15, 2025, the President of the United States signed Executive Order 14272 initiating a U.S. Department of Commerce investigation under Section 232 of the Trade Expansion Act of 1962, to determine whether imports of processed critical minerals, including uranium, and their derivative products threaten to impair national security. Following the investigation, on January 14, 2026, the President issued Proclamation 11001, which directed the Secretary of Commerce and the United States Trade Representative (“USTR”) to pursue negotiations with trading partners over the next 180 days to ensure the United States maintains adequate supplies of critical minerals while mitigating supply-chain vulnerabilities affecting processed critical minerals and their derivative products. Proclamation 11001 indicated that, depending on the status or outcome of those negotiations, alternative remedies may be considered in the future, including the imposition of an additional sectoral tariff. The imposition of new or increased tariffs on these products or other trade restrictions from our international suppliers could significantly increase our costs and have a material adverse effect on our financial position and results of operations.
Read it in 10-K Feb 11, 2026 at sec.gov
RemovedMD&A
On November 6, 2024, DOE issued requests for task order proposals under the HALEU Deconversion Contract and the HALEU Enrichment Contracts. DOE contemplates issuing the task orders on a time-and-material basis with a two year period of performance for the purpose of describing the technical approach and price in a optimization study to support DOE in establishing the commercial production of HALEU and commercial deconversion of HALEU, respectively. On January 9, 2025, we submitted our proposals in response to these requests for task order proposals.
Read it in 10-K Feb 7, 2025 at sec.gov
RemovedMD&A
On December 20, 2024, the Department of Energy’s National Nuclear Security Administration (“NNSA”) announced that it had released a Request for Information (“RFI”) for industry input on an AC100 Deployment Demonstration to address the need for a new domestic uranium enrichment capability. This AC100 deployment demonstration will provide a limited early production capability, demonstrate one of the available centrifuge technologies, and reduce risk to meeting the NNSA defense mission requirements. The deployment demonstration will provide NNSA with data required to determine which technology or technologies may be deployed for the full range of NNSA defense mission requirements. This effort is consistent with NNSA’s approach to meet its defense mission requirements by incrementally deploying centrifuge technologies, with candidates including the AC100 centrifuge and the Domestic Uranium Enrichment Centrifuge Experiment (“DUECE”) centrifuge being developed by Oak Ridge National Laboratory (“ORNL”). NNSA’s incremental approach enables the phase-in of low-enriched uranium (LEU) production capacity as soon as possible to ensure timely delivery of LEU for defense mission requirements. The Company intends to respond to the RFI.
Read it in 10-K Feb 7, 2025 at sec.gov
RemovedMD&A
address these changes, we have taken steps to adjust our cost structure; we may seek further adjustments to our cost structure and operations and evaluate opportunities to grow our business organically or through acquisitions and other strategic transactions.
Read it in 10-K Feb 7, 2025 at sec.gov
RemovedMD&A
On July 13, 2023, the Company and TerraPower, LLC (“TerraPower”) entered into a memorandum of understanding (“MOU”) to expand their collaboration aimed at establishing commercial-scale, domestic production capabilities for HALEU to fuel the NatriumTM reactor that TerraPower is building in Wyoming. Under this MOU, the Company and TerraPower will explore collaboration to ensure the Natrium demonstration reactor has access to HALEU at the milestones necessary to meet the project's 2030 operation date. Subject to a definitive agreement to be negotiated, Centrus would work toward scaling up production capacity with additional centrifuge cascades to meet TerraPower's fuel requirements.
Read it in 10-K Feb 7, 2025 at sec.gov
RemovedMD&A
On August 28, 2023, the Company and Oklo Inc. (“Oklo”) announced a new MOU to support the deployment of Oklo’s advanced fission powerhouses and advanced nuclear fuel production in Southern Ohio subject to a definitive agreement to be negotiated. Oklo and Centrus plan to enter into a broad range of collaboration programs supporting the development and operation of Oklo’s Aurora powerhouses, including supply of HALEU produced by Centrus at the Piketon, Ohio facility. Centrus also intends to buy clean, reliable, and affordable energy from Oklo’s planned Ohio plants to power its HALEU production facility.
Read it in 10-K Feb 7, 2025 at sec.gov
RemovedMD&A
The Company measures Net Income and Net Income per Share both on a GAAP basis and on an adjusted basis to exclude deemed dividends allocable to the warrant modification (“Adjusted Net Income” and “Adjusted Net Income per Share”). We believe Adjusted Net Income and Adjusted Net Income per Share, which are non-GAAP financial measures, provide investors with additional understanding of the Company’s financial performance as well as its strategic financial planning analysis and period-to-period comparability. These metrics are useful to investors because they reflect how management evaluates the Company’s ongoing operating performance from period-to-period after removing certain transactions and activities that affect comparability of the metrics and are not reflective of the Company’s core operations.
Read it in 10-K Feb 7, 2025 at sec.gov
RemovedMD&A
The Company believes its LEU segment backlog is a source of stability for our liquidity position. Subject to market conditions, we see the potential for growing uncommitted demand for LEU during the next few years with accelerated open demand in 2025 and beyond.
Read it in 10-K Feb 7, 2025 at sec.gov
RemovedMD&A
The indenture governing the 8.25% Notes includes restrictions on the ability of Enrichment Corp. to transfer cash and other assets to the Company, which could constrain the Company’s ability to pay dividends on its Common Stock or to fund its commitments or the commitments of its other subsidiaries, subject to certain exceptions, such as the transfer of inventory and other assets in the ordinary course of business of Enrichment Corp. The indenture also restricts the Company’s ability to engage in certain mergers or acquisitions and requires the Company to offer to repurchase all such outstanding notes at 101% of their outstanding principal amount in the event of certain change of control events.
Read it in 10-K Feb 7, 2025 at sec.gov
RemovedMD&A
Interest on the 8.25% Notes is payable semi-annually in arrears as of February 28 and August 31 based on a 360-day year consisting of twelve 30-day months. The 8.25% Notes are guaranteed on a subordinated and limited basis by, and secured by substantially all assets of, Enrichment Corp. The 8.25% Notes mature on February 28, 2027. Additional terms and conditions of the 8.25% Notes are described in Note 8, Debt, of the Consolidated Financial Statements in Part IV of this Annual Report.
Read it in 10-K Feb 7, 2025 at sec.gov
RemovedMD&A
On May 28, 2024, the Company entered into a Sixth Amendment approved by the Board and makes clarifying changes relating to the definition of “Beneficial Owner”, “beneficially owned” and “Beneficial Ownership” contained in the Rights Agreement. The Sixth Amendment was not adopted as a result of or in response to, any effort to acquire control of the Company.
Read it in 10-K Feb 7, 2025 at sec.gov
RewordedMD&A
Nonoperating Components of Net Periodic Benefit Income Loss (Income) netted to loss of $6.8 million, income of $14.7 million, and income of $23.2 million, and $6.6 million for the year ended December 31, 2025, 2024, and 2023, and 2022, including a net actuarial loss of $2.9 million, gain of $17.9 million for the year ended December 31, 2024, net actuarial million, and gain of $24.6 million for the year ended December 31, 2025, 2024, and 2023, and net actuarial loss of $7.8 million for the year ended December 31, 2022. respectively.
Read it in 10-K Feb 11, 2026 at sec.gov
RewordedMD&A
The Company filed a an automatic shelf registration statement on Form S-3 (Registration Statement (File No. 333-272984) 333-291305) with the SEC on June 28, 2023, November 6, 2025, which became effective on July 10, 2023. was supplemented by a prospectus supplement dated November 6, 2025.
Read it in 10-K Feb 11, 2026 at sec.gov
RewordedMD&A
Changes If this trend continues, it will likely result in significant changes in the competitive landscape that will affect pricing trends, change affect customer spending patterns, create uncertainty and create uncertainty. likely have a negative impact on our business.
Read it in 10-K Feb 11, 2026 at sec.gov
RewordedMD&A
The shares of Class A Common Stock were issued pursuant to (a) the Company’s automatic shelf registration on Form S-3 (File No. 333-291305) and a prospectus supplement dated November 6, 2025, (b) the Company’s shelf registration statement on Form S-3 (File No. 333-272984), which became effective on July 10, 2023, and a prospectus supplement dated February 9, 2024 and (c ) the Company’s shelf registration statement on Form S-3 (File No. 333-239242), which became effective on August 5, 2020, and two prospectus supplements dated December 31, 2020 and December 5, 2022, respectively. 2022.
Read it in 10-K Feb 11, 2026 at sec.gov
RewordedMD&A
Nonoperating components of net periodic benefit income was $14.7 loss (income) netted to a loss of $6.8 million and $23.2 income of $14.7 million for the year ended December 31, 2024 2025 and 2023, 2024, respectively, a decrease change of $8.5 $21.5 million (or 37%). 146%).
Read it in 10-K Feb 11, 2026 at sec.gov
RewordedMD&A
During November 2023, the Company transitioned to Phase 2 of the HALEU Operation Contract. Contract, which included production of 900 kilograms of HALEU UF6 for one production year, as well as continued operations and maintenance of the cascade.
Read it in 10-K Feb 11, 2026 at sec.gov
RewordedMD&A
On November 5, 2024, the HALEU Operation Contract was modified to extend the Phase 2 period of performance to June 30, 2025. 2025, which allowed the Company to produce and contractually deliver the Phase 2 production target of 900 kilograms of HALEU UF6 to DOE.
Read it in 10-K Feb 11, 2026 at sec.gov
RewordedMD&A
On November 7, 2024, August 18, 2025, the Company issued, in a Rule 144A offering, 2.25% issued 0% Convertible Notes with an aggregate principal amount of $402.5 $805.0 million, due November 1, 2030, August 15, 2032, unless earlier repurchased, redeemed or converted.
Read it in 10-K Feb 11, 2026 at sec.gov
RewordedMD&A
The ultimate dollar amount under each contract value of the awards to Centrus, and the potential scale of the expansion supported supported, will depend upon the scope of task orders that DOE may subsequently issue to Centrus under the contracts for which we will the Company intends to compete.
Read it in 10-K Feb 11, 2026 at sec.gov
RewordedMD&A
In the United States, the industry has been under pressure from the expansion of subsidized renewable energy as well as relatively low-cost natural gas resources in recent years, although natural gas prices in the U.S. electricity sector tripled between 2020 and 2022 according to data from the EIA. years.
Read it in 10-K Feb 11, 2026 at sec.gov
RewordedMD&A
Revenue from Cost of sales for the LEU segment was $349.9 $234.7 million and $269.0 $256.0 million for the year ended December 31, 2024 2025 and 2023, 2024, respectively, an increase a decrease of $80.9 $21.3 million (or 30%). 8%).
Read it in 10-K Feb 11, 2026 at sec.gov
RewordedMD&A
Uranium costs decreased while SWU revenue costs increased $38.6 million (or 19%) as a result of a 24% 23% increase in the average price volume of SWU sold, partially offset by a 4% 13% decrease in the volume average unit cost of SWU sold.
Read it in 10-K Feb 11, 2026 at sec.gov
Quiet changesMD&A
However, Centrus has been informed that there is no certainty whether additional licenses will be issued by the Russian authorities and if issued, whether they will be issued in a timely manner and not rescinded prior to the shipment taking place.
Read it in 10-K Feb 11, 2026 at sec.gov
Quiet changesMD&A
If TENEX refuses to make future deliveries or otherwise suspends deliveries for an extended period under the TENEX Supply Contract, our delivery obligations to our customers would be negatively impacted, including which would have a material adverse effect on the Company.
Read it in 10-K Feb 11, 2026 at sec.gov

Sources

The two latest 10-Ks on EDGAR, section by section. Each change links to the text at sec.gov.

Also

New risk factors: paragraphs with nothing like them last year, quoted in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/LEU/export.csv") into a cell.

Next:Related parties
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.